Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
Jayne DigbyCallum G FraserGavin R C ClarkCraig MowatJudith A StrachanRobert James Campbell SteelePublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2024)
The RSM conferred no significant benefit to patients with very low f-Hb and CRC. Alternative strategies combining FIT with other variables may be more appropriate for safety-netting of symptomatic patients. Further work to develop and investigate the value of RSM for significant bowel disease other than CRC may also be beneficial.